Company Filing History:
Years Active: 2020-2022
Title: Innovations by Ellen Catherine MacDonald
Introduction
Ellen Catherine MacDonald is a prominent inventor based in Cambridge, GB. She has made significant contributions to the field of biotechnology, particularly in the development of compounds that inhibit autotaxin enzyme activity. With a total of 2 patents, her work is crucial in addressing various proliferative disorders, including cancer.
Latest Patents
Ellen's latest patents focus on autotaxin inhibitory compounds. The present invention relates to compounds of formula I, wherein A, A, A, R, R, R, R, R, R, L, Ar, and Q are each as defined in the patent documentation. These compounds serve as inhibitors of autotaxin (ATX) enzyme activity. Furthermore, the invention encompasses processes for the preparation of these compounds, pharmaceutical compositions that include them, and their application in treating proliferative disorders, such as cancer, as well as other diseases or conditions like fibrosis, where ATX activity is implicated.
Career Highlights
Ellen is currently associated with Cancer Research Technology Limited, where she continues to advance her research and innovations. Her work is instrumental in the development of therapeutic solutions that target critical health issues.
Collaborations
Ellen collaborates with notable colleagues, including Martin Stockley and Pritom Shah, to further enhance her research efforts and drive innovation in the field.
Conclusion
Ellen Catherine MacDonald is a key figure in the realm of biotechnology, with her innovative patents paving the way for new treatments in cancer and other diseases. Her contributions are vital to the ongoing fight against proliferative disorders.